These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 20636829)

  • 21. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
    van Werkum JW; Topcu Y; Postma S; Kelder JC; Hackeng CM; ten Berg JM; Verheugt FW
    Thromb Haemost; 2008 Mar; 99(3):637-9. PubMed ID: 18327417
    [No Abstract]   [Full Text] [Related]  

  • 22. Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel.
    Ang L; Palakodeti V; Khalid A; Tsimikas S; Idrees Z; Tran P; Clopton P; Zafar N; Bromberg-Marin G; Keramati S; Mahmud E
    J Am Coll Cardiol; 2008 Sep; 52(13):1052-9. PubMed ID: 18848137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of increasing doses of aspirin on platelet function as measured by PFA-100 in patients with diabetes.
    Abaci A; Yilmaz Y; Caliskan M; Bayram F; Cetin M; Unal A; Cetin S
    Thromb Res; 2005; 116(6):465-70. PubMed ID: 16181981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes.
    Lange S; Diehm C; Darius H; Haberl R; Allenberg JR; Pittrow D; Schuster A; von Stritzky B; Tepohl G; Trampisch HJ
    Exp Clin Endocrinol Diabetes; 2004 Nov; 112(10):566-73. PubMed ID: 15578331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coated-platelet levels in patients with Type 1 and with Type 2 diabetes mellitus.
    Jenkins AJ; Gosmanova AK; Lyons TJ; May KD; Dashti A; Baker MZ; Olansky L; Aston CE; Dale GL
    Diabetes Res Clin Pract; 2008 Aug; 81(2):e8-10. PubMed ID: 18508150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation.
    van Halm VP; Peters MJ; Voskuyl AE; Boers M; Lems WF; Visser M; Stehouwer CD; Spijkerman AM; Dekker JM; Nijpels G; Heine RJ; Bouter LM; Smulders YM; Dijkmans BA; Nurmohamed MT
    Ann Rheum Dis; 2009 Sep; 68(9):1395-400. PubMed ID: 18697775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes mellitus: a cardiovascular disease.
    Candido R; Srivastava P; Cooper ME; Burrell LM
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1088-94. PubMed ID: 14582453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of the effect of picotamide on platelet function in diabetic subjects].
    Carleo R; Veno L; Fuccio F; Bonavita M; De Matteo A; Gallo M; Gatti A; Gobbo M; Nocerino L
    Boll Soc Ital Biol Sper; 1990 Jul; 66(7):647-54. PubMed ID: 2083059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.
    Soedamah-Muthu SS; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin for primary prevention in patients with diabetes mellitus.
    Nguyen KX; Marinac JS; Sun C
    Fam Med; 2005 Feb; 37(2):112-7. PubMed ID: 15690251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of non-treatment with statins of high risk patients in The Netherlands.
    van den Haak P; Heintjes E; Plat AW; Jan Meerding W; Webb K; Sturkenboom MC; Herings RM
    Curr Med Res Opin; 2010 Feb; 26(2):271-8. PubMed ID: 19929592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of antiplatelet therapy in patients with diabetes.
    Miller SR; Littenberg B; MacLean CD
    Cardiovasc Diabetol; 2005 Dec; 4():18. PubMed ID: 16321162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy of anti-platelet therapy in thrombosis].
    Kawano K
    Nihon Naika Gakkai Zasshi; 2000 Jun; 89(6):1126-30. PubMed ID: 10892188
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical study of blood platelet disorders. Discussion].
    Nihon Naika Gakkai Zasshi; 1993 Jul; 82(7):1073-87. PubMed ID: 8228486
    [No Abstract]   [Full Text] [Related]  

  • 35. An association between anti-platelet drug use and reduced cancer prevalence in diabetic patients: results from the Vermont Diabetes Information System Study.
    Holmes CE; Ramos-Nino ME; Littenberg B
    BMC Cancer; 2010 Jun; 10():289. PubMed ID: 20546622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-platelets in diabetes management.
    Grantham NM; Magliano DJ; Tai G; Cohen N; Shaw JE
    Intern Med J; 2010 Jun; 40(6):458-62. PubMed ID: 20636829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study.
    Angiolillo DJ; Shoemaker SB; Desai B; Yuan H; Charlton RK; Bernardo E; Zenni MM; Guzman LA; Bass TA; Costa MA
    Circulation; 2007 Feb; 115(6):708-16. PubMed ID: 17261652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres.
    González-Clemente JM; Piniés JA; Calle-Pascual A; Saavedra A; Sánchez C; Bellido D; Martín-Folgueras T; Moraga I; Recasens A; Girbés J; Sánchez-Zamorano MA; Mauricio D;
    Diabet Med; 2008 Apr; 25(4):427-34. PubMed ID: 18341592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet perturbations in diabetes: implications for cardiovascular disease risk and treatment.
    Mathewkutty S; McGuire DK
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):541-9. PubMed ID: 19419262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.